Biotest AG/ DE0005227201 /
| 9/20/2023 9:21:12 AM | Chg. - | Volume | Bid- | Ask5:29:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 40.30EUR | - | 5,943 Turnover: 239,819.60 |
-Bid Size: - | -Ask Size: - | 2.41 bill.EUR | - | 12.69 |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 477.1000 | 512.7000 | 521.9000 | 522.2000 | 524.7000 | ||||||
| Intangible Assets | 16.6000 | 16.4000 | 13.8000 | 14 | 11.3000 | ||||||
| Long-Term Investments | 13 | 7.4000 | 7.6000 | .2000 | 5.6000 | ||||||
| Fixed Assets | 528.8000 | 547.2000 | 585.6000 | 575 | 582 | ||||||
| Inventories | 146.9000 | 208.3000 | 280.1000 | 290.1000 | 244.6000 | ||||||
| Accounts Receivable | 133.8000 | 118.7000 | 107.7000 | 115.8000 | 107.3000 | ||||||
| Cash and Cash Equivalents | 22.3000 | 61.9000 | 60.8000 | 71.3000 | 104.4000 | ||||||
| Current Assets | 449.7000 | 495.1000 | 522.8000 | 556.3000 | 522.2000 | ||||||
| Total Assets | 978.5000 | 1,042.3000 | 1,108.4000 | 1,131.3000 | 1,104.2000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 65 | 73.4000 | 52.2000 | 42 | 38.8000 | ||||||
| Long-term debt | 286.8000 | 328.7000 | 402.9000 | 462.5000 | 496.4000 | ||||||
| Liabilities to Banks | 406.4000 | 329.4000 | 410.4000 | 470.4000 | 531.2000 | ||||||
| Provisions | 30.6000 | 29.3000 | 28.9000 | 29.4000 | 25 | ||||||
| Liabilities | 630.7000 | 547.1000 | 631.5000 | 689.7000 | 723.8000 | ||||||
| Share Capital | 39.6000 | 39.6000 | 39.6000 | 39.6000 | 39.6000 | ||||||
| Total Equity | 347.6000 | 495 | 476.9000 | 441.6000 | 380.4000 | ||||||
| Minority Interests | .2000 | .2000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 978.5000 | 1,042.3000 | 1,108.4000 | 1,131.3000 | 1,104.2000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 378.1000 | 400.3000 | 419.1000 | 484.2000 | 515.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -9.3000 | 10.6000 | -1.2000 | -1.3000 | -47.1000 | ||||||
| Interest Income | -16.8000 | -11.3000 | -10.5000 | -28.2000 | -16.8000 | ||||||
| Income Before Taxes | -26 | -6 | -1.3000 | -30 | -62.6000 | ||||||
| Income Taxes | -9.6000 | 6.9000 | 3.4000 | 1.4000 | .7000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -3.5000 | 181.7000 | -4.7000 | -31.4000 | -63.4000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 34.3000 | -50 | -33.6000 | -16.7000 | 33.9000 | ||||||
| Cash Flow from Investing Activities | -148 | 200.8000 | -8 | -14.6000 | -23.4000 | ||||||
| Cash Flow from Financing | 55.2000 | -111.2000 | 40.5000 | 42 | 22.6000 | ||||||
| Decrease / Increase in Cash | -58.5000 | 39.6000 | -1.1000 | 10.7000 | 33.1000 | ||||||
| Employees | 2,683 | 1,663 | 1,837 | 1,928 | 1,967 | ||||||
